BRCA2 and cancer: In our previous article,5 using data from the Hospital-based Epidemiological Research Program at Aichi Cancer Center (HERPACC), we assessed the impact of Germline Pathogenic Variants (GPVs) of cancer-predisposing genes, such as BRCA1 or BRCA2, on breast cancer risk.